NV

NVST ENVISTA HOLDINGS CORP

2026Q2 · CUSIP 29415F104 · Sector: Healthcare & Biotech

Funds left

Funds are exiting, but the price is holding

Funds that own it
383
Institutions that reported holding it to the SEC
Net decrease in holders
6
Last quarter 389 → now 383
How unusual is that
Bottom 20%
Stronger than only 13% of US stocks
What the filings say, in one paragraph

383 funds held NVST at the end of 2026Q2, down 6 from the quarter before. Buying has faded, though the price is holding up. On the business itself, revenue over the last 12 months was $2.9B(YoY +11.9%), the P/E is 40.8x, return on equity is 3.1%. NVST has had 8 buying rushes in its history, and the price moved +8.0% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2019Q4: holders=211 2020Q1: holders=191 2020Q2: holders=182 2020Q3: holders=201 2020Q4: holders=265 2021Q1: holders=292 2021Q2: holders=328 2021Q3: holders=319 2021Q4: holders=321 2022Q1: holders=349 2022Q2: holders=336 2022Q3: holders=321 2022Q4: holders=329 2023Q1: holders=311 2023Q2: holders=316 2023Q3: holders=310 2023Q4: holders=315 2024Q1: holders=298 2024Q2: holders=293 2024Q3: holders=297 2024Q4: holders=292 2025Q1: holders=290 2025Q2: holders=286 2025Q3: holders=312 2025Q4: holders=335 2026Q1: holders=389 2026Q2: holders=383 -137 -68.5 +0 +68.5 +137 163286409 19Q420Q321Q222Q122Q423Q324Q225Q125Q426Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 8 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q1 Top 5% +18.8% +15.8%
2025Q3 Top 20% +18.0% +50.3%
2022Q1 Top 10% -7.5% -4.3%
2021Q2 Top 10% +4.6% +5.9%
2021Q1 Top 20% -2.3% -8.9%
2020Q4 Top 10% +8.5% +17.3%
2020Q3 Top 20% +21.7% +33.6%
2019Q4 Top 5% -51.1% -45.7%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
186
Change in large funds
+15
Total value they hold
$5.0B
Funds buying for the first time
53
Funds that sold out entirely
59
Price change that quarter
+19.4%
Funds holding puts (bearish)
1
Funds holding calls (bullish)
3

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

Fundamentals

PE (TTM)
40.8
EPS (TTM)
$0.58
EPS YoY
+87.1%
Revenue (TTM)
$2.9B
Revenue YoY
+11.9%
Net margin
3.3%
ROE
3.1%
Debt ratio
45.0%
FCF (TTM)
$248M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-10-01: EPS 0.52 2021-12-31: EPS 0.24 2022-04-01: EPS 0.42 2022-07-01: EPS 0.26 2022-09-30: EPS 0.27 2022-12-31: EPS 0.42 2023-03-31: EPS 0.25 2023-06-30: EPS 0.29 2023-09-29: EPS 0.12 2023-12-31: EPS -1.26 2024-03-29: EPS 0.14 2024-06-28: EPS -6.69 2024-09-27: EPS 0.05 2024-12-31: EPS 0.00 2025-03-28: EPS 0.10 2025-06-27: EPS 0.16 2025-09-26: EPS -0.18 2025-12-31: EPS 0.20 2026-04-03: EPS 0.23 2026-07-03: EPS 0.33 0M 380M 759M $M -7.36 -3.39 0.57 20182019202020212022202320242025202607/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 31 19 142 264 20222023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-76M52M180M 201820192020202120222023202420252026
Latest quarter $-16M (2026-04-03)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-07-03 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.